Worldwide Cardiac Monitoring Industry to 2027 - Growing Focus on Mergers & Acquisitions is Driving the Market

DUBLIN, June 8, 2022 /PRNewswire/ -- The "Global Cardiac Monitoring Market - Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

COVID-19 led to an increasing preference for remote monitoring patients with cardiovascular conditions. The government and some vendors have also taken various steps to raise awareness among patients and the public. September marks National Atrial Fibrillation (AF) Awareness Month, a critically important time for the Heart Rhythm Society to raise awareness for this life-threatening arrhythmia.

The market is expected to grow significantly during the forecast period due to increasing technological advancements, new product launches, increasing elderly population, and reimbursement policies for implantable cardiac monitors & other ambulatory devices. Moreover, the COVID-19 impact will result in AI-based cardiac monitoring devices gaining traction across all regions.

The cardiac monitoring market is expected to grow at a CAGR of 5.86% during the forecast period. In-depth analysis and data-driven insights on the impact of COVID-19 are included in this report.

Market Opportunities and Growth Drivers

• Technological Advancements in Cardiac Monitoring
• Increase in Demand for Compact, Mobile, & Wearable Cardiac Monitors
• Artificial Intelligence in Cardiac Monitoring
• The increasing global prevalence of cardiovascular diseases
• Growing Popularity of Smart Wearable Cardiac Monitoring Devices

The Global Cardiac Monitoring Market is segmented based on Product, Mode, End-user, and Geography. Based on products, the global cardiac monitoring is segmented into resting ECG, stress ECG, cardiac event monitors, Holter monitors, output monitoring devices, implantable cardiac monitoring devices, and mobile cardiac telemetry. The resting ECG segment accounted for a major share of 38.95% in 2021. In developing countries, physicians are forced to use resting ECG devices instead of the latest high-end devices due to the cost-effective factor. This is driving growth in resting ECG devices sales.

Based on mode, the global cardiac monitoring market is segmented into standard and ambulatory. The ambulatory cardiac monitoring market will grow with an absolute rate of 79.5% in the forecast period. Based on end-user, the global Cardiac Monitoring market is segmented into hospitals, specialty cardiac centers and clinics, diagnostic centers and others.The hospital segment had the highest share amongst end-users.

Vendor Landscape

Major vendors in the cardiac monitoring market include Abbott, Boston Scientific, Medtronic, GE Healthcare, Philips Healthcare, Mortara Instrument and Welch Allyn owned by Hill-Rom Services, Spacelabs Healthcare owned by OSI Systems, and iRhythm Technologies.

The Report Includes:
1. The analysis of the global cardiac monitoring market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the cardiac monitoring market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the global cardiac monitoring market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segmentation
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Mode
4.4.3 Market Segmentation by End-User
4.4.4 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview
7.1.1 Cardiac Monitoring Devices
7.1.2 Ambulatory Cardiac Monitoring
7.1.3 Privacy & Data Security for Wearable Cardiac Monitoring Platforms
7.1.4 Digital Health Adoption Increasing in Cardiac Monitoring

8 Market Opportunities & Trends
8.1 Technological Advances in Cardiac Monitoring Devices
8.2 Increase in Demand for Compact, Mobile, & Wearable Cardiac Monitors
8.3 Artificial Intelligence in Cardiac Monitoring

9 Market Growth Enablers
9.1 Increasing Global Prevalence of Cardiovascular Diseases
9.2 Growing Popularity of Smart Wearable Cardiac Monitoring Devices
9.3 New Product Launches in Cardiac Monitoring Market
9.4 Growing Focus on Mergers & Acquisitions

10 Market Growth Restraints
10.1 Limitations & Risks Associated with Cardiac Monitoring Devices
10.2 Stringent Regulatory Scenario
10.3 Dearth of Skilled Professionals
10.4 High Cost of Equipment & Infrastructure

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Geography Insights
11.2.2 Product Insights
11.2.3 Usage Mode Insights
11.2.4 End-User Insights
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry

12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Resting ECG
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Resting ECG: Geography Segmentation
12.4 Stress ECG
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Stress ECG: Geography Segmentation
12.5 Cardiac Event Monitoring
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.5.3 Cardiac Event Monitoring: Geography Segmentation
12.6 Mobile Cardiac Telemetry
12.6.1 Market Overview
12.6.2 Market Size & Forecast
12.6.3 Mobile Cardiac Telemetry: Geography Segmentation
12.7 Holter Monitoring
12.7.1 Market Overview
12.7.2 Market Size & Forecast
12.7.3 Holter Monitoring: Geography Segmentation
12.8 Cardiac Output Monitoring
12.8.1 Market Overview
12.8.2 Market Size & Forecast
12.8.3 Cardiac Output Monitoring: Geography Segmentation
12.9 Implantable Cardiac Monitoring
12.9.1 Market Overview
12.9.2 Market Size & Forecast
12.9.3 Implantable Cardiac Monitoring: Geography Segmentation

13 Mode
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Ambulatory
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Ambulatory: Geography Segmentation
13.4 Standard
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Standard: Geography Segmentation

14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Hospitals
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Hospitals: Geography Segmentation
14.4 Specialty Cardiac Centers & Clinics
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Specialty Cardiac Centers & Clinics: Geography Segmentation
14.5 Diagnostic Centers
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Diagnostic Centers: Geography Segmentation
14.6 Others
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Others: Geography Segmentation

15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview

16 North America

17 Europe

18 APAC

19 Latin America

20 Middle East & Africa

21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Abbott
21.2.2 Boston Scientific
21.2.3 Ge Healthcare
21.2.4 Hill-Rom Services
21.2.5 IRHYTHM Technologies
21.2.6 Medtronic
21.2.7 OSI Systems
21.2.8 KONINKLIJKE Philips

22 Key Company Profiles
22.1 ABBOTT
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 BOSTON SCIENTIFIC CORPORATION
22.2.1 Market Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 GE HEALTHCARE
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 HILL-ROM SERVICES
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 IRHYTHM TECHNOLOGIES
22.5.1 Market Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
22.6 MEDTRONIC
22.6.1 Business Overview
22.6.2 Product Offerings
22.6.3 Key Strategies
22.6.4 Key Strengths
22.6.5 Key Opportunities
22.7 OSI SYSTEMS
22.7.1 Market Overview
22.7.2 Product Offerings
22.7.3 Key Strategies
22.7.4 Key Strengths
22.7.5 Key Opportunities
22.8 KONINKLIJKE PHILIPS
22.8.1 Business Overview
22.8.2 Product Offerings
22.8.3 Key Strategies
22.8.4 Key Strength
22.8.5 Key Opportunities

23 Other Prominent Vendors
23.1 BPL MEDICAL TECHNOLOGIES
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 BIOTRONIK
23.2.1 Market Overview
23.2.2 Product Offerings
23.3 BARDY DIAGNOSTICS
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 BITTIUM
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 CORTRIUM
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 DELTEX MEDICAL
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 EDWARDS LIFESCIENCES
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 FUKUDA DENSHI
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 GETINGE
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 MASIMO
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 MEDICALGORITHMICS
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 AEROTEL MEDICAL SYSTEMS
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 ACS DIAGNOSTICS
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 SCOTTCARE CARDIOVASCULAR SOLUTIONS
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 VASO CORPORATION
23.15.1 Business Overview
23.15.2 Product Offerings
23.16 SCHILLER
23.16.1 Business Overview
23.16.2 Product Offerings
23.17 ALIVECOR
23.17.1 Business Overview
23.17.2 Product Offerings
23.18 CARDIOCOMM SOLUTIONS
23.18.1 Business Overview
23.18.2 Product Offerings
23.19 IMEDRIX
23.19.1 Business Overview
23.19.2 Product Offerings
23.20 CONNECTED CARE INDIA
23.20.1 Business Overview
23.20.2 Product Offerings
23.21 ADVANCED INSTRUMENTATIONS
23.21.1 Business Overview
23.21.2 Product Offerings
23.22 AMEDTEC MEDIZINTECHNIK AUE
23.22.1 Business Overview
23.22.2 Product Offerings
23.23 ASPEL
23.23.1 Business Overview
23.23.2 Product Offerings
23.24 HANGZHOU BENEWARE MEDICAL EQUIPMENT
23.24.1 Business Overview
23.24.2 Product Offerings
23.25 BIOTRICITY
23.25.1 Business Overview
23.25.2 Product Offerings
23.26 BORSAM BIOMEDICAL INSTRUMENTS
23.26.1 Business Overview
23.26.2 Product Offerings
23.27 BTL
23.27.1 Business Overview
23.27.2 Product Offerings
23.28 CONTEC MEDICAL SYSTEMS
23.28.1 Business Overview
23.28.2 Product Offerings
23.29 CUSTO MED
23.29.1 Business Overview
23.29.2 Product Offerings
23.30 OY DIAGNOSTIC DEVICES DEVELOPMENT (DDD)
23.30.1 Business Overview
23.30.2 Product Offerings
23.31 DMS-SERVICE
23.31.1 Business Overview
23.31.2 Product Offerings
23.32 EB NEURO
23.32.1 Business Overview
23.32.2 Product Offerings
23.33 EDAN INSTRUMENTS
23.33.1 Business Overview
23.33.2 Product Offerings
23.34 FOREST MEDICAL
23.34.1 Business Overview
23.34.2 Product Offerings
23.35 HOLTER SUPPLIES
23.35.1 Business Overview
23.35.2 Product Offerings
23.36 LABTECH
23.36.1 Business Overview
23.36.2 Product Offerings
23.37 LEPU MEDICAL TECHNOLOGY (BEIJING)
23.37.1 Business Overview
23.37.2 Product Offerings
23.38 LUMED
23.38.1 Business Overview
23.38.2 Product Offerings
23.39 MEDICAL ECONET
23.39.1 Business Overview
23.39.2 Product Offerings
23.40 MEDICOMP
23.40.1 Business Overview
23.40.2 Product Offerings
23.41 MEDITECH KFT.
23.41.1 Business Overview
23.41.2 Product Offerings
23.42 MEDITECH EQUIPMENT
23.42.1 Business Overview
23.42.2 Product Offerings
23.43 MIDMARK
23.43.1 Business Overview
23.43.2 Product Offerings
23.44 MONITOR
23.44.1 Business Overview
23.44.2 Product Offerings
23.45 NASAN MEDICAL ELECTRONICS
23.45.1 Business Overview
23.45.2 Product Offerings
23.46 NASIFF ASSOCIATES
23.46.1 Business Overview
23.46.2 Product Offerings
23.47 NEUROSOFT
23.47.1 Business Overview
23.47.2 Product Offerings
23.48 NORAV MEDICAL
23.48.1 Business Overview
23.48.2 Product Offerings
23.49 NORTHEAST MONITORING
23.49.1 Business Overview
23.49.2 Product Offerings
23.50 RHYTHMEDIX
23.50.1 Business Overview
23.50.2 Product Offerings
23.51 REMO CARE SOLUTIONS
23.51.1 Business Overview
23.51.2 Product Offerings

24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations

25 Quantitative Summary

26 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/f0xuyc

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets